Liver Injury Associated With Kratom ( Mitragyna speciosa ): A Systematic Review [0.03%]
kratom(Mitragynaspeciosa)相关性肝损伤的系统评价
Xavier Alexander Calicdan,Anika Kopczynski,Edwin Medina et al.
Xavier Alexander Calicdan et al.
Objectives: Kratom ( Mitragyna speciosa ) is a psychoactive herbal product increasingly used for pain, anxiety, and opioid withdrawal. Although marketed as a natural dietary product, concerns have emerged regarding advers...
Trends and Predictors of Prescription Drug Substance Use Disorders in the United States: The Role of Recovery Capital [0.03%]
美国药物使用障碍的流行趋势及其影响因素：康复资本的作用
Mayu Koga,Simon Coulombe,Hideaki Tanaka et al.
Mayu Koga et al.
Objectives: To examine trends and predictors of prescription drug substance use disorders (RxSUDs), highlighting risk and protective factors, with a particular focus on patient recovery capital (social factors known to pr...
Rapid Buprenorphine Initiations for Cardiac Emergencies in Patients on High-dose Methadone: A Case Report [0.03%]
高剂量美沙酮维持治疗患者因心脏急症快速启动布洛芬治疗的病例报告
Eloise Fourie,Megan T Mitchell,Paul Anaya et al.
Eloise Fourie et al.
Background: Methadone remains the most utilized medication for opioid use disorder (MOUD) with significant mortality reduction. Methadone carries a black box warning for the prolongation of the corrected QT interval (QTc)...
Opioid Agonist Therapy for Fentanyl-Related Opioid Use Disorder: A Systematic Review [0.03%]
芬太尼相关性阿片类物质使用障碍的阿片受体激动剂治疗系统评价
Austin Daniel Solak,Jack Boynton,Jacob Riches et al.
Austin Daniel Solak et al.
Objectives: While treatment guidelines for opioid use disorder (OUD) are well-established, specific guidance for people who use fentanyl remains limited. This systematic review is the first to examine effectiveness and sa...
Low-threshold Buprenorphine: Proposing the Ideal Service Model to Engage People With Severe Opioid Use Disorder [0.03%]
低剂量丁丙诺啡：提出理想的服务模式以使患有严重阿片类物质使用障碍的人群获益
Aaron D Fox,Sarah E Messmer,Benjamin T Hayes et al.
Aaron D Fox et al.
Low-threshold buprenorphine treatment has been described as a general approach to office-based buprenorphine treatment that prioritizes access to care, flexibility, and patient-centeredness. Proposed principles have included same-day treatm...
Metabolism, Not Mendacity: Rethinking Prolonged Cocaine Positivity [0.03%]
代谢问题，而非撒谎问题：重新思考长期可卡因阳性的问题
Daniel M Bowen,Maryam Soltani
Daniel M Bowen
Background: Urine toxicology is a cornerstone of monitoring abstinence in substance use disorder treatment, yet commonly cited detection windows are based on studies in healthy volunteers and do not account for metabolic ...
Gains in Employment Status Are Associated With Lower Methamphetamine Use Frequency at Outpatient Specialty Treatment Discharge [0.03%]
就业状况的改善与门诊专科治疗出院时较低的甲基苯丙胺使用频率相关
Nicholas L Bormann,Tyler S Oesterle,Andrea N Weber et al.
Nicholas L Bormann et al.
Objectives: Employment can provide structure and economic opportunity. We examined whether changes in employment status from treatment admission to discharge co-occurred with changes in methamphetamine use frequency over ...
Estimated Prevalence of Current Posttraumatic Stress Disorder Among Pregnant Women With Opioid Use Disorder-MATernaL and Infant Clinical NetworK (MAT-LINK), 2014-2021 [0.03%]
2014-2021年美国 MATernal和婴幼儿临床网络(MAT-LINK)中妊娠合并阿片类药物使用障碍的当前创伤后应激障碍患病率估算
Kelly R Peck,Min-Hsuan Chen,Brianna Lee et al.
Kelly R Peck et al.
Objectives: Posttraumatic stress disorder (PTSD) during pregnancy is associated with adverse consequences and has an estimated prevalence of 3% in community samples. The prevalence of current PTSD among pregnant women wit...
When a Withdrawal Aid Mimics a Brainstem Lesion: Gabapentin-associated Transient Ophthalmoplegia [0.03%]
一种撤药反应模拟脑干病变：加巴喷丁相关性短暂眼肌麻痹
Maryam Soltani
Maryam Soltani
Objectives: Gabapentin is frequently used as a benzodiazepine-sparing agent for the management of mild to moderate alcohol withdrawal and is generally considered well-tolerated. Although neurological adverse effects have ...
Treatment of Kratom Use Disorder With Methadone in an Opioid Treatment Program [0.03%]
含甲基安非他命治疗项目中 kratom使用障碍的治疗
Robert C Sherrick
Robert C Sherrick
Background: Kratom (Mitragyna speciosa) and its active alkaloids, mitragynine and 7-hydroxymitragynine, can produce opioid-like dependence and withdrawal meeting DSM-5 criteria for opioid use disorder (OUD). While bupreno...